Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ABHD12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAST4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC37B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SH3TC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDOR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXNB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
B4GALT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPKC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBGCP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on